• YC-1 Workflow for Hypoxia and Cancer Research

  2026-08-26

  YC-1 combines HIF-1α pathway interrogation with soluble guanylyl cyclase biology, making it useful for integrated hypoxia, angiogenesis, viability, and apoptosis experiments. This workflow explains how to build controlled dose-response studies, connect molecular and functional readouts, and troubleshoot solubility or pathway-specificity problems.

• Central Control of Morphine Mechanical Hypersensitivity

  2026-08-25

  Yin et al. identify a brain-to-spinal opioid circuit linking lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal KOR-expressing GABAergic neurons in morphine-induced mechanical hypersensitivity and analgesic tolerance. The findings refine opioid receptor pharmacology by showing how disruption of central gate control can produce paradoxical mechanical pain during repeated opioid exposure.

• Tetraethylammonium Chloride: Assay Workflows

  2026-08-24

  Build more informative potassium-channel experiments with Tetraethylammonium chloride (TEAC), from pore-access studies to vascular and β-cell workflows. This guide emphasizes controlled exposure, orthogonal readouts, practical preparation, and troubleshooting rather than treating TEAC as a universally selective blocker.

• Boc-D-FMK: Assay Workflows for Apoptosis Research

  2026-08-24

  Boc-D-FMK provides a practical causal test for caspase-dependent cell death while also helping dissect inflammatory signaling in endothelial and hepatic models. This guide combines product-backed handling parameters with a precision-oncology workflow inspired by recent CYP2B6 and ATF5 findings in glioblastoma.

• Chenodeoxycholic Acid (CDCA) Assay Guide

  2026-08-23

  A practical, scenario-based guide to using Chenodeoxycholic Acid in viability, proliferation, cytotoxicity, and FXR-focused cell studies. It explains formulation, solvent controls, dose-response design, interpretation, and vendor-selection considerations for SKU B1908.

• Tofacitinib Citrate: From JAK3 to Vascular Insight

  2026-08-22

  Tofacitinib citrate (CP-690550 citrate) is widely used to interrogate JAK-STAT signaling, lymphocyte biology, and inflammatory responses. This thought-leadership analysis connects its established immune-regulatory role with a 2025 endothelial-cell study, showing why cytokine suppression should not be equated with vascular normalization. The article provides translational framing, assay parameters, concentration-aware guidance, and a strategic approach to interpreting JAK inhibitor phenotypes.

• Cyanidin Chloride: From Redox Probe to Cell Insight

  2026-08-21

  Cyanidin Chloride can support a more rigorous bridge between cell-free antioxidant measurements and cellular protection assays. This article explains how to distinguish direct reactive oxygen species scavenging from downstream inflammatory and barrier effects while designing reproducible oxidative stress research workflows.

• Thioguanine: From Mechanism to Translational Strategy

  2026-08-20

  Thioguanine, also known as 6-thioguanine, is more than a conventional thiopurine immunosuppressant. Its HGPRT-linked metabolic activity and reported DNA methyltransferase 1 modulation create a translational framework spanning cancer cell proliferation inhibition, EV71 virus inhibition, and inflammatory bowel disease treatment.

• GS967: From Late INa Mechanism to Assay Design

  2026-08-20

  GS967 is a cardiac late sodium current inhibitor for connecting ventricular myocyte sodium current inhibition with repolarization, calcium handling, and arrhythmia phenotypes. This article develops an assay-design framework informed by Nav1.5 Ser571 biology and aging-related electrophysiology.

• ERCC1 Deficiency, p53, and Cisplatin Response in Lung Cancer

  2026-08-19

  Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that the response to ERCC1 deficiency and cisplatin depends strongly on p53 status. The study identifies a synthetic-viability phenotype in which p53 disruption reduces apoptosis and improves survival despite impaired ERCC1-associated interstrand crosslink repair, highlighting why ERCC1 alone may be an inadequate platinum-response biomarker.

• Pam3CSK4 in Neuroimmune Inflammation Research

  2026-08-19

  Pam3CSK4 is a defined TLR1/2 agonist for dissecting immune cell activation, allergic inflammation, and neuroimmune regulation. This article connects receptor-level stimulation with the somato-autonomic reflex while separating established evidence from testable experimental hypotheses.

• Sulfachloropyridazine: Workflows for Microbial Research

  2026-08-18

  Sulfachloropyridazine supports mechanistic DHPS inhibition studies, antimicrobial susceptibility testing, and microbiome-focused infection research. Its strongest use-case is a connected workflow that links bacterial folate-pathway activity with cecal community and metabolite changes.

• Omeprazole (A2845) for Acid Secretion Research

  2026-08-18

  Omeprazole (A2845) provides a research reagent for probing H+,K+-ATPase inhibition and stimulus-associated gastric acid secretion. It is intended for mechanistic and preclinical workflows only, not for diagnosis, treatment, or direct clinical use.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows

  2026-08-17

  SCH772984 HCl enables acute ERK pathway suppression, transcription-factor studies, and longer-term proliferation assays in one experimental framework. This guide connects hypothalamic Agrp regulation with BRAF- and RAS-driven cancer models while emphasizing dose design, controls, and troubleshooting.

• Stat3, NF-κB, and Fyn in Zebrafish Neurodegeneration

  2026-08-17

  A 2024 Disease Models & Mechanisms study develops a neural-specific zebrafish model of constitutively active Fyn and identifies Stat3 as a previously underappreciated downstream mediator of dopaminergic neuron loss and microglial inflammation. The findings also show functional cooperation between Stat3 and NF-κB, providing a mechanistic framework for testing pathway-selective interventions in neurodegeneration research.

555 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page